Microbiota-produced indole metabolites disrupt mitochondrial function and inhibit Cryptosporidium parvum growth
Cell Reports · 2023
DOI: 10.1016/j.celrep.2023.112680 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Lisa J Funkhouser-Jones und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA. Hauptthemen laut MEDLINE: Cryptosporidium parvum, Cryptosporidiosis, Cryptosporidium, Microbiota. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Cryptosporidiosis is a leading cause of life-threatening diarrhea in young children in resource-poor settings. To explore microbial influences on susceptibility, we screened 85 microbiota-associated metabolites for their effects on Cryptosporidium parvum growth in vitro. We identify eight inhibitory metabolites in three main classes: secondary bile salts/acids, a vitamin B6 precursor, and indoles. Growth restriction of C. parvum by indoles does not depend on the host aryl hydrocarbon receptor (AhR) pathway. Instead, treatment impairs host mitochondrial function and reduces total cellular ATP, as well as directly reducing the membrane potential in the parasite mitosome, a degenerate mitochondria. Oral administration of indoles, or reconstitution of the gut microbiota with indole-producing bacteria, delays life cycle progression of the parasite in vitro and reduces the severity of C. parvum infection in mice. Collectively, these findings indicate that microbiota metabolites impair mitochondrial function and contribute to colonization resistance to Cryptosporidium infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.
- Department of Medicine, Division of Infectious Diseases, Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO, USA.
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
- Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA. Electronic address: sibley@wustl.edu.
Förderung
- NIAID NIH HHS
- NIDDK NIH HHS
- NCI NIH HHS
- NCATS NIH HHS
- National Institutes of Health
- Institute of Clinical and Translational Sciences
- National Cancer Institute
- Alvin J. Siteman Cancer Center
Zitieren
APA
Funkhouser-Jones, L. J., Xu, R., Wilke, G., Fu, Y., Schriefer, L. A., Makimaa, H., Rodgers, R., Kennedy, E. A., VanDussen, K. L., Stappenbeck, T. S., Baldridge, M. T., & Sibley, L. D. (2023). Microbiota-produced indole metabolites disrupt mitochondrial function and inhibit Cryptosporidium parvum growth. Cell Reports. https://doi.org/10.1016/j.celrep.2023.112680
Vancouver
Funkhouser-Jones LJ, Xu R, Wilke G, Fu Y, Schriefer LA, Makimaa H, et al. Microbiota-produced indole metabolites disrupt mitochondrial function and inhibit Cryptosporidium parvum growth. Cell Reports. 2023. doi:10.1016/j.celrep.2023.112680
BibTeX
@article{FunkhouserJones2023,
author = {Funkhouser-Jones, Lisa J and Xu, Rui and Wilke, Georgia and Fu, Yong and Schriefer, Lawrence A and Makimaa, Heyde and Rodgers, Rachel and Kennedy, Elizabeth A and VanDussen, Kelli L and Stappenbeck, Thaddeus S and Baldridge, Megan T and Sibley, L David},
title = {Microbiota-produced indole metabolites disrupt mitochondrial function and inhibit Cryptosporidium parvum growth},
journal = {Cell Reports},
year = {2023},
doi = {10.1016/j.celrep.2023.112680}
}
EUVIMED